跳至主要内容
临床试验/NCT04533503
NCT04533503已完成不适用

Post-Market Clinical Evaluation of the Gentuity High-Frequency Optical Coherence Tomography Imaging System and Vis-Rx Micro-Imaging Catheter

Gentuity, LLC3 个研究点 分布在 1 个国家目标入组 257 人开始时间: 2021年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Gentuity, LLC
入组人数
257
试验地点
3
主要终点
Clinical performance

研究概览

简要总结

Post-market clinical evaluation of the Gentuity High-Frequency Optical Coherence Tomography (HF-OCT) System and the Vis-Rx Micro-Imaging Catheter for use in Percutaneous Coronary Intervention (PCI) procedures.

详细描述

Prospective, single-arm, unblinded, multi-center, post-market clinical evaluation assessing the imaging capabilities of the Gentuity HF-OCT System and the Vis-Rx Micro-Imaging Catheter for use in PCI procedures. Objectives are to evaluate the clinical and technical performance in the target patient population.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Willing and able to provide written informed consent to participate
  • Transluminal interventional procedure for their coronary arteries

排除标准

  • Bacteremia or sepsis
  • Major coagulation system abnormalities
  • Severe hemodynamic instability or shock
  • Acute renal failure
  • Disqualified for Coronary Artery Bypass Graft (CABG) surgery
  • Disqualified for PCI procedure
  • Currently enrolled in another study to evaluate an investigational device or medication
  • Lesion-Specific Exclusion Criteria:
  • Total occlusion
  • Coronary artery spasm
  • Large thrombus (visible under angiography)
  • Any target vessel which has undergone a bypass procedure

结局指标

主要结局

Clinical performance

时间窗: Immediately after the procedure

Operator evaluation of performance via Likert scale

Technical performance

时间窗: Up to 3 months following the procedure

Objective measurement of image clarity of the HF-OCT images by an independent core lab

次要结局

  • Complete pullbacks(Up to 3 months following the procedure)

研究者

发起方
Gentuity, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Vis-Rx Post-Market Evaluation | 临床试验